Serum microRNA Landscape in Eosinophilic Granulomatosis with Polyangiitis: A Hypothesis-Generating Reference Dataset
Authors: Kamide, Yosuke; Sonehara, Kyuto; Ueki, Shigeharu; Furukawa, Yoshihiro; Nakamura, Yuto; Fukutomi, Yuma; Sekiya, Kiyoshi; Okada, Yukinori; Taniguchi, Masami
Source journal: International archives of allergy and immunology (2026-11-19)
DOI: 10.1159/iaa/adfag045
Abstract
INTRODUCTION: Eosinophilic granulomatosis with polyangiitis (EGPA) is an eosinophilic vasculitis arising against a background of adult-onset asthma. We investigated circulating microRNA (miRNA) profiles in EGPA and integrated them with previously reported serum protein data. METHODS: In this retrospective, cross-sectional study, archived sera from 14 patients with active, glucocorticoid-naive EGPA and 20 with severe eosinophilic asthma without EGPA were profiled on a 2,588-miRNA microarray. Differential expression among 1,777 quantifiable miRNAs was assessed with limma, adjusting for sex and RNA integrity number; significance required both a Benjamini-Hochberg false discovery rate below 0.05 and a Bonferroni-corrected p below 0.05. TargetScan-predicted target genes were intersected with 29 serum proteins previously shown to differ between the same groups. Two further paired analyses, each performed in a separate group of patients with EGPA, compared active disease with the glucocorticoid-treated phase (n = 11) and samples before versus after mepolizumab (n = 13). RESULTS: Eight miRNAs met both criteria: hsa-miR-3126-5p, hsa-miR-921, hsa-miR-6836-5p and hsa-miR-668-5p were lower in EGPA, and hsa-miR-6857-3p, hsa-miR-1260a, hsa-miR-603 and hsa-miR-12125 were higher (within-cohort areas under the curve, 0.82-0.94). Fourteen of the 29 proteins were encoded by predicted target genes. Only hsa-miR-3678-3p changed after glucocorticoid treatment; no miRNA changed after mepolizumab, and none of the eight EGPA-associated miRNAs changed with either treatment. CONCLUSION: This exploratory study identifies circulating miRNA differences between EGPA and severe eosinophilic asthma, and the complete result table is provided as a reference resource. Independent validation is required to establish their biological and clinical significance. TRIAL REGISTRATION: UMIN000040163.
Related topics
Related open access articles
- MicroRNA-20a-3p and microRNA-20a-5p exhibit anti-proliferative activities in a melanoma in vitro model
- microRNA expression profiling in human diploid cells infected with enterovirus 71 or coxsackievirus A16
- Effects of ATRA on proliferation, migration and cell cycle of gastric cancer MGC-803 cells
- Caveolin-1 inhibits proliferation and migration of gastric cancer cell via inactivating BMI-1
- Expression of Oct4 and RhoA in gastric cancer and their correlation with clinicopathological characteristics
- Effects of Black Vinegar and Niacinamide on LPS-Induced Inflammation on Human Keratinocytes
Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.